Friday, January 25, 2008 2:37:28 PM
$0,15 in no time
MANHATTAN PHARMACEUTICAL STOCK BEST BUY 2008
MANHATTAN PHARMACEUTICAL COMES WITH HEDRIN
PIPELINE:
Topical
PTH (1-34)
Psoriasis
Phase 1/2
----------
Altoderm™
Atopic
Dermatitis
(eczema)
Pruritus
Pre-IND (US)
----------
Hedrin™
Pre-IND (US)
------------------->NON TOXIC
(marketed in europe and the United Kingdom)
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM